Preoperative statin therapy for patients undergoing cardiac surgery

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Kuhn, Elmar W ^a   Slottosch, Ingo ^a   Wahlers, Thorsten ^a   Liakopoulos, Oliver J ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; DISPERSITY; DOSE; DRUG EFFECT; HEART INFARCTION; HEART SURGERY; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT TERM SURVIVAL; SYSTEMATIC REVIEW; TREATMENT DURATION; ADVERSE EFFECTS; META ANALYSIS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; RENAL INSUFFICIENCY; STROKE;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; STROKE;

EID: 84991217640     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008493.pub3     Document Type: Review

References (165)

1. Almansob MA, Xu B, Zhou L, Hu XX, Chen W, Chang FJ, et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. Arteriosclerosis, Thrombosis, and Vascular Biology 2012;32(9):2304-13. [PUBMED: 22796581]
2. Ou, Jing-song . Effect of Simvastatin on Cardiac Function. www.clinicaltrials.gov. Last update July 25, 2012.
3. Baran C, Durdu S, Dalva K, Zaim C, Dogan A, Ocakoglu G, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Reviews 2012;8(3):963-71. [PUBMED: 22076751]
4. Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. The Thoracic and Cardiovascular Surgeon 2009;57(2):91-5. [PUBMED: 19241310]
5. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. European Cytokine Network 2008;19(2):99-103. [PUBMED: 18632424]
6. Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agro F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine 2006;34(3):660-7. [PUBMED: 16505650]
7. Christenson JT. Preoperative lipid control with simvastatin protects coronary artery bypass from obstructive graft disease. The American Journal of Cardiology 2001;88(8):896-9. [PUBMED: 11676957]
8. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio-thoracic Surgery 1999;15(4):394-9; discussion 399-400. [PUBMED: 10371111]
9. Florens E, Salvi S, Peynet J, Elbim C, Mallat Z, Bel A, et al. Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. Journal of Cardiac Surgery 2001;16(3):232-9. [PUBMED: 11824669]
10. Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circulation Journal 2009;73(12):2244-9. [PUBMED: 19822977]
11. Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. The Journal of Thoracic and Cardiovascular Surgery 2008;136(6):1541-8. [PUBMED: 19114204]
12. Melina G, Angeloni E, Di Nucci G, Benedetto U, Fiorani B, Sclafani G, et al. Preoperative HMG-CoA reductase inhibitors and atrial fibrillation in patients undergoing CABG: a prospective randomised trial. European Heart Journal 2009;30:32.
13. Candura C, Chello M, Lusini M, Patti G, Barbato R, Di Sciascio G, et al. A randomised trial of atorvastatin for reduction of myocardial damage during CABG: the ARMYDA-4 study (atorvastatin for reduction of myocardial damage). Interactive CardioVascular and Thoracic Surgery; Abstracts for EACTS Congress 2008; Vol. 7.
14. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114(14):1455-61. [PUBMED: 17000910]
15. Patti G, Chello M, Candura D, Pasceri V, D'ambrosio A, Nusca A, et al. A randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery. Abstracts for ESC Congress 2006.
16. Bellomo R. Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial (CREAT). www.clinicaltrials.gov. Last update September 9, 2012.
17. Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton, Vic.) 2012;17(3):215-24. [PUBMED: 22117606]
18. Sasmazel A, Baysal A, Fedekar A, Buyukbayrak F, Bugra O, Erdem H, et al. The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery. The Heart Surgery Forum 2010;13(4):E243-6. [PUBMED: 20719727]
19. Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. American Heart Journal 2008;156(2):373.e9-16. [PUBMED: 18657672]
20. Spadaccio C, Pollari F, Casacalenda A, Alfano G, Genovese J, Covino E, et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology 2010;55(1):30-8. [PUBMED: 19834333]
21. Sun Y, Ji Q, Mei Y, Wang X, Feng J, Cai J, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. International Heart Journal 2011;52(1):7-11. [PUBMED: 21321461]
22. Tamayo E, Alonso O, Alvarez FJ, Castrodeza J, Florez S, di Stefano S. Effects of simvastatin on acute-phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentration de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica 2008;130(20):773-5. [PUBMED: 18579030]
23. Tamayo E, Alvarez FJ, Alonso O, Bustamante R, Castrodeza J, Soria S, et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. The Journal of Cardiovascular Surgery 2009;50(5):687-94. [PUBMED: 19741581]
24. Ali IS, Buth KJ. Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina. European Journal of Cardio-thoracic Surgery 2005;27(6):1051-6. [PUBMED: 15896616]
25. Ambrosi P. [Short-term clinical effects of periprocedural statin therapy] [Effets cliniques a court terme des statines initiees avant une intervention.]. Presse Medicale 2013;42(3):261-8. [PUBMED: 22884240]
26. Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 2011;124(3):335-45. [PUBMED: 21730307]
27. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Lee R, Demosthenous M, et al. Oral atorvastatin treatment improves NO bioavailability and vascular redox state in the human arterial wall, via a tetrahydrobiopterin-mediated improvement of eNOS coupling. Circulation 22 Nov 2011;1:1. [: Accession Number 70618705]
28. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Lee R, Demosthenous M, et al. Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis. European Heart Journal August 2011;32:989. [: Accession Number 70536767]
29. Antoniades C, Bakogiannis C, Tousoulis D, Zhang MH, Demosthenous M, Antonopoulos A, et al. Preoperative atorvastatin treatment rapidly improves vein graft redox state by inhibiting rac1 and NADPH oxidase activity in patients undergoing elective CABG. European Heart Journal September 2010;31:310. [DOI: http://dx.doi.org/10.1093/eurheartj/ehq288;: Accession Number 70280690]
30. Antoniades C, Demosthenous M, Margaritis M, Tousoulis D, Antonopoulos A, Paschalis A, et al. Short-term preoperative treatment with atorvastatin improves myocardial redox state in patients undergoing elective CABG by affecting NADPH oxidase activity and NOS coupling. European Heart Journal September 2010;31:60. [DOI: http://dx.doi.org/10.1093/eurheartj/ehq287;: Accession Number 70279719]
31. Antoniades, C.Demosthenous, M.Reilly, S.Margaritis, M.Jayaram, R.Nahar, K.Tousoulis, D.Stefanadis, C.Channon, K. M.Casadei, B . Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL owering. European Heart Journal August 2011;32:76. [DOI: http://dx.doi.org/10.1093/eurheartj/ehr322;: Accession Number 70533326]
32. Antoniades C, Bakagiannis C, Tousoulis D, Zhang M-H, Demosthenous M, Antonopoulos A, et al. Preoperative atorvastatin treatment rapidly improves vein graft redox state by inhibiting rac1 and NADPH oxidase activity in patients undergoing elective CABG. European Heart Journal; abstract supplement for ESC Congress 2010; Vol. 31.
33. Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang MH, Paschalis A, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation 2010;122(11 Suppl):S66-73. [PUBMED: 20837928]
34. Antoniades C, Demosthenous M, Reilly S, Margaritis M, Zhang MH, Antonopoulos A, et al. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. Journal of the American College of Cardiology 2012;59(1):60-70. [PUBMED: 22192670]
35. Baigent C, Landray MJ, Reith C. Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney disease. Annals of Internal Medicine December 2011;155:JC5-2. [: Accession Number 2011626751]
36. Barbir M, Hunt BJ, Galloway D, Taylor A, Ilsley C, Mitchell A, et al. A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting. Clinical Cardiology 1994;17(2):59-64. [PUBMED: 8162627]
37. Borger MA, Seeburger J, Walther T, Borger F, Rastan A, Doenst T, et al. Effect of preoperative statin therapy on patients undergoing isolated and combined valvular heart surgery. The Annals of Thoracic Surgery 2010;89(3):773-9; discussion 779-80. [PUBMED: 20172126]
38. Brophy JM, Brassard P, Bourgault C. The benefit of cholesterol-lowering medications after coronary revascularization: a population study. American Heart Journal 2005;150(2):282-6. [PUBMED: 16086931]
39. Brull DJ, Sanders J, Rumley A, Lowe GD, Humphries SE, Montgomery HE. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. The American Journal of Cardiology 2001;88(4):431-3. [PUBMED: 11545771]
40. Candura C, Chello M, Lusini M, Patti G, Barbato R, Sciascio G. A randomised trial of atorvastatin for reduction of myocardial damage during CABG: the ARMYDA-4 study (atorvastatin for reduction of myocardial damage). Interactive CardioVascular and Thoracic Surgery 2008;7:674-8. [: Accession Number CN-00865939]
41. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England Journal of Medicine 2004;350(15):1495-504. [PUBMED: 15007110]
42. Carrier M, Cossette M, Pellerin M, Hebert Y, Bouchard D, Cartier R, et al. Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts. The Annals of Thoracic Surgery 2009;88(3):789-95; discussion 795. [PUBMED: 19699899]
43. Chello M, Mastroroberto P, Patti G, D'Ambrosio A, Morichetti MC, Di Sciascio G, et al. Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart (British Cardiac Society) 2003;89(5):538-43. [PUBMED: 12695460]
44. Chello M, Carassiti M, Agro F, Mastroroberto P, Pugliese G, Colonna D, et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 2004;18(5):605-9. [PUBMED: 15578471]
45. Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. European Journal of Cardio-thoracic Surgery 2005;28(6):805-10. [PUBMED: 16274999]
46. Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G, et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. The Annals of Thoracic Surgery 2007;83(4):1374-80. [PUBMED: 17383342]
47. Cherkanova MS, Korolenko TA, Bravve IIu, Gerasimova TP. The activity of metalloproteinases and concentration of C-reactive protein in the blood of patients with coronary heart disease during the administration of statins and coronary artery bypass surgery. Klinicheskaia Laboratornaia Diagnostika 2009;6:9-11. [PUBMED: 19642578]
48. Cherkanova MS, Korolenko TA, Bravve IIu, Gerasimova TP. [Effect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients after coronary artery bypass surgery]. Kardiologiia 2012;52(2):23-8. [PUBMED: 22792735]
49. Christenson JT. Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery (London, England) 2001;9(1):33-43. [PUBMED: 11137806]
50. Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E, Lusini M, et al. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study. Clinical Therapeutics 2007;29(8):1706-17. [PUBMED: 17919551]
51. Collard CD, Body SC, Shernan SK, Wang S, Mangano DT. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. The Journal of Thoracic and Cardiovascular Surgery 2006;132(2):392-400. [PUBMED: 16872968]
52. Dereli Y, Ege E, Kurban S, Narin C, Sarigul A, Yeniterzi M. Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting. The Journal of International Medical Research 2008;36(6):1248-54. [PUBMED: 19094433]
53. Dong L, Zhang F, Shu X. Usefulness of statins pretreatment for the prevention of postoperative atrial fibrillation in patients undergoing cardiac surgery. Annals of Medicine 2011;43(1):69-74. [PUBMED: 21108566]
54. Dotani MI, Elnicki DM, Jain AC, Gibson CM. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. The American Journal of Cardiology 2000;86(10):1128-30, A6. [PUBMED: 11074212]
55. Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. The American Journal of Cardiology 2003;91(9):1107-9. [PUBMED: 12714156]
56. Fedoruk LM, Wang H, Conaway MR, Kron IL, Johnston KC. Statin therapy improves outcomes after valvular heart surgery. The Annals of Thoracic Surgery 2008;85(5):1521-5; discussion 1525-6. [PUBMED: 18442531]
57. Huffmyer JL, Mauermann WJ, Thiele RH, Ma JZ, Nemergut EC. Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 2009;23(4):468-73. [PUBMED: 19157909]
58. Kabir S, Hjortshoj S, Schmidt EB, Arya A, Christensen JH, Lundbye-Christensen S, et al. High dose atorvastatin therapy and QTc interval in patients treated with coronary bypass surgery. International Journal of Cardiology 2013; Vol. 168, issue 2:1526-8. [PUBMED: 23181999]
59. Kasai T, Miyauchi K, Kajimoto K, Kubota N, Kurata T, Amano A, et al. The impact of pravastatin therapy on long-term outcome in patients with metabolic syndrome undergoing complete coronary revascularization. Circulation Journal 2009;73(11):2104-9. [PUBMED: 19713652]
60. Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O, et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. The Annals of Thoracic Surgery 2008;85(5):1515-20. [PUBMED: 18442529]
61. Kourliouros A, Valencia O, Hosseini MT, Mayr M, Sarsam M, Camm J, et al. Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. The Journal of Thoracic and Cardiovascular Surgery 2011;141(1):244-8. [PUBMED: 20624624]
62. Krivoy N, Adler Z, Saloma R, Hawadie A, Azzam ZS. Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery. Experimental and Clinical Cardiology 2008;13(4):171-4. [PUBMED: 19343161]
63. Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 2008;118(18):1785-92. [PUBMED: 18852363]
64. Kumar A, Kapoor A, Agarwal SK, Tewari S, Pandey S, Sharma MK, et al. Randomized trial of high vs low-dose atorvastatin for reduction of myocardial damage following coronary artery bypass graft surgery [abstract]. Indian Heart Journal 2006;58(5):Abstract.
65. Kurban S, Mehmetoglu I, Ege E. Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting. Perfusion 2009;24(4):271-6. [PUBMED: 19843623]
66. Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, Coleman CI. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. The Journal of Thoracic and Cardiovascular Surgery 2008;135(2):405-11. [PUBMED: 18242276]
67. Liakopoulos OJ, Dorge H, Schmitto JD, Nagorsnik U, Grabedunkel J, Schoendube FA. Effects of preoperative statin therapy on cytokines after cardiac surgery. The Thoracic and Cardiovascular Surgeon 2006;54(4):250-4. [PUBMED: 16755446]
68. Ludman AJ, Hausenloy DJ, Babu G, Hasleton J, Venugopal V, Boston-Griffiths E, et al. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. Basic Research in Cardiology 2011;106(6):1387-95. [PUBMED: 21833652]
69. Ludman AJ, Hausenloy DJ, Venugopal V, Babu G, Boston-Griffiths E, Lawrence D, et al. The effect of high-dose atorvastatin on a background of standard-dose chronic statin therapy in patients undergoing cardiac surgery. European Heart Journal September 2010;31:70. [DOI: http://dx.doi.org/10.1093/eurheartj/ehq287;: Accession Number 70279760]
70. Lysgaard C, Nielsen MS, Christensen JH, Lundbye-Christensen S, Riahi S, Schmidt EB. No effect of high-dose atorvastatin on leukotriene B(4) formation from neutrophils in patients treated with coronary bypass surgery: a randomized placebo-controlled double-blinded trial with a crossover design. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2012;87(6):185-8. [PUBMED: 23063168]
71. Margaritis M, Antoniades C. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond. Expert Review of Cardiovascular Therapy 2012; Vol. 10, issue 1:5-8. [PUBMED: 22149521]
72. Mariscalco G, Lorusso R, Klersy C, Ferrarese S, Tozzi M, Vanoli D, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. The Annals of Thoracic Surgery 2007;84(4):1158-64. [PUBMED: 17888963]
73. Martinez-Comendador JM, Alvarez JR, Mosquera I, Sierra J, Adrio B, Carro JG, et al. Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery. European Journal of Cardio-thoracic Surgery 2009;36(6):998-1005. [PUBMED: 19581104]
74. Miceli A, Fino C, Fiorani B, Yeatman M, Narayan P, Angelini GD, et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. The Annals of Thoracic Surgery 2009;87(6):1853-8. [PUBMED: 19463608]
75. Mohamed R, McAlister FA, Pretorius V, Kapoor AS, Majumdar SR, Ross DB, et al. Preoperative statin use and infection after cardiac surgery: a cohort study. Clinical Infectious Diseases 2009;48(7):e66-72. [PUBMED: 19228110]
76. Mukamal KJ, Smith CC, Karlamangla AS, Moore AA. Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial. The American Journal of Medicine 2006;119(5):434-40. [PUBMED: 16651056]
77. Muraki S, Kawaharada N, Higami T. Potential use of statins in reducing atrial fibrillation after off-pump coronary artery bypass grafting surgery. Circulation Journal 2010; Vol. 74, issue 9:1798-9. [PUBMED: 20702956]
78. Nakamura K, Masuda H, Kariyazono H, Arima J, Iguro Y, Yamada K, et al. Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. Cytokine 2006;36(5-6):201-10. [PUBMED: 17300951]
79. On YK. Atorvastatin for prevention of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. American Heart Journal 2008;156(2):373.e9-16. [: Accession Number CN-00867070]
80. Ouattara A, Benhaoua H, Le Manach Y, Mabrouk-Zerguini N, Itani O, Osman A, et al. Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 2009;23(5):633-8. [PUBMED: 19362495]
81. Ozaydin M, Dogan A, Varol E, Kapan S, Tuzun N, Peker O, et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007;107(2):117-21. [PUBMED: 16864965]
82. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110(11 Suppl 1):II45-9. [PUBMED: 15364837]
83. Papathanasiou A, Toumpoulis IK, Milionis HJ, Kalantzi K, Katsouras CS, Goudevenos J. Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery. Coronary Artery Disease 2008;19(8):619-25. [PUBMED: 19005297]
84. Pascual DA, Arribas JM, Tornel PL, Marin F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. The Annals of Thoracic Surgery 2006;81(1):78-83. [PUBMED: 16368340]
85. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Nusca A. A randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery. Abstracts for ESC Congress 2006. [: Accession Number CN-00867069]
86. Patti G, Chello M, Gatto L, Alfano G, Miglionico M, Covino E, et al. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. Journal of Cardiovascular Medicine (Hagerstown, Md) 2010;11(11):795-800. [PUBMED: 20613550]
87. Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, D'Ambrosio A, et al. Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial. The American Journal of Cardiology 2011;108(1):1-7. [PUBMED: 21529740]
88. Post S, Post MC, van den Branden BJ, Eefting FD, Goumans MJ, Stella PR, et al. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial. Catheterization and Cardiovascular Interventions 2012;80(5):756-65. [PUBMED: 22419603]
89. Prowle JR, Licari E, Calzavacc P, Ligabo EV, Echeverri JE, Hasse M, et al. Peri-operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: creat, the cardiopulmonary bypass, renal injury and atorvastatin trial. Intensive Care Medicine September 2010;36:S88. [DOI: http://dx.doi.org/10.1007/s00134-010-1999-x;: Accession Number 70290230]
90. Radaelli A, Loardi C, Cazzaniga M, Balestri G, DeCarlini C, Cerrito MG, et al. Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination. Arteriosclerosis, Thrombosis, and Vascular Biology 2007;27(12):2750-5. [PUBMED: 17823365]
91. Sharma MK, Kapoor A, Agarwal SK, Tewari S, Pandey S, Singh SK, et al. Randomized trial of high versus low-dose atorvastatin for reduction of myocardial damage following coronary artery bypass graft surgery. Indian Heart Journal 2005;57(5):Abstract.
92. Song, YB, On YK, Kim JH, Park MJ, Sung KI, Lee YT, Kim JS, Lee SH. Pretreatment with statins protects against atrial fibrillation after coronary artery bypass graft surgery. Europace Abstract 2007.
93. Subramaniam K, Koch CG, Bashour A, O'Connor M, Xu M, Gillinov AM, et al. Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. Journal of Clinical Anesthesia 2008;20(1):4-11. [PUBMED: 18346602]
94. Sun Y, Qi G, Gao Y, Zhang H, Pang X, Zhao W, et al. Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes. The Canadian Journal of Cardiology 2010;26(9):481-5. [PUBMED: 21076721]
95. Sun YF, Mei YQ, Ji Q, Wang XS, Feng J, Cai JZ, et al. [Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting]. Zhonghua Yi Xue Za Zhi 2009;89(42):2988-91. [PUBMED: 20137710]
96. Tabata M, Khalpey Z, Pirundini PA, Byrne ML, Cohn LH, Rawn JD. Renoprotective effect of preoperative statins in coronary artery bypass grafting. The American Journal of Cardiology 2007;100(3):442-4. [PUBMED: 17659925]
97. Tabata M, Khalpey Z, Cohn LH, Chen FY, Bolman RM 3rd, Rawn JD. Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery 2008;136(6):1510-3. [PUBMED: 19114199]
98. Takagi H, Umemoto T. Effect of preoperative statin therapy on postoperative atrial fibrillation in cardiac surgery. Circulation Journal 2010; Vol. 74, issue 12:2788-9; author reply 2790. [PUBMED: 20921813]
99. Thielmann M, Neuhauser M, Marr A, Jaeger BR, Wendt D, Schuetze B, et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. The Journal of Thoracic and Cardiovascular Surgery 2007;134(5):1143-9. [PUBMED: 17976441]
100. Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. American Heart Journal 2008;155(3):541-6. [PUBMED: 18294494]
101. Bavry A, Winchester D. Evidence for pre-procedural statin therapy: meta-analysis of randomized trials. European Heart Journal September 2010;31:600. [DOI: http://dx.doi.org/10.1093/eurheartj/ehq289;: Accession Number 70281810]
102. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. Journal of the American College of Cardiology 2010;56(14):1099-109. [PUBMED: 20825761]
103. Yu XL, Zhang HJ, Ren SD, Geng J, Wu TT, Chen WQ, et al. Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury. Coronary Artery Disease 2011;22(1):87-91. [PUBMED: 21169815]
104. Zhang M, Kang JP, Nie SP, Lv Q, Liu XH, Ma CS. Pre-hospital statin therapy may not reduce incidence of all-cause mortality and overall MACCE during hospital stay after coronary artery bypass graft surgery. Acta Cardiologica 2009;64(2):253-7. [PUBMED: 19476120]
105. NCT00791648 . Short-term atorvastatin's effect on acute kidney injury following cardiac surgery. https://clinicaltrials.gov/ct2/show/NCT00791648 (accessed 3 April 2014).
106. NCT01573143 . Statin therapy in cardiac surgery (STICS). https://clinicaltrials.gov/ct2/show/NCT01573143 (accessed 3 April 2014).
107. NCT01780740 . Statin therapy in atrial refractoriness and reperfusion injury (STARR). https://clinicaltrials.gov/ct2/show/NCT01780740 (accessed 3 April 2014).
108. NCT02084069 . Atorvastatin for preventing atrial fibrillation following open cardiac valve repair. https://clinicaltrials.gov/ct2/show/NCT02084069 (accessed 3 April 2014).
109. NCT00811330 . Effects of high dose atorvastatin in patients with surgical aortic stenosis. https://clinicaltrials.gov/ct2/show/NCT00811330 (accessed 3 April 2014).
110. NCT01909739 . The effects of statin on postoperative renal function in valvular heart surgery: a randomized, placebo-controlled study. https://clinicaltrials.gov/ct2/show/NCT01909739 (accessed 3 April 2014).
111. NCT01715714 . Statin recapture therapy before coronary artery bypass grafting (StaRT-CABG). https://clinicaltrials.gov/ct2/show/NCT01715714 (accessed 3 April 2014).
112. NCT01653223 . Myocardial protection effect of simvastatin undergoing cardiac surgery. https://clinicaltrials.gov/ct2/show/NCT01653223 (accessed 3 April 2014).
113. NCT01624857 . Statin for depression in patients undergoing coronary artery bypass graft (Stress CABG). https://clinicaltrials.gov/ct2/show/NCT01624857 (accessed 3 April 2014).
114. Alexander JH, Emery RW Jr, Carrier M, Ellis SJ, Mehta RH, Hasselblad V, et al. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA 2008;299(15):1777-87. [PUBMED: 18381567]
115. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology 2006;6:50. [PUBMED: 17038197]
116. Bourbon A, Vionnet M, Leprince P, Vaissier E, Copeland J, McDonagh P, et al. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. European Journal of Cardio-thoracic Surgery 2004;26(5):932-8. [PUBMED: 15519185]
117. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ (Clinical research ed.) 2009;338:b2376. [PUBMED: 19567909]
118. Chen WT, Krishnan GM, Sood N, Kluger J, Coleman CI. Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. The Journal of Thoracic and Cardiovascular Surgery 2010;140(2):364-72. [PUBMED: 20381820]
119. Clark LL, Ikonomidis JS, Crawford FA Jr, Crumbley A III, Kratz JM, Stroud MR, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. Journal of Thoracic and Cardiovascular Surgery 2006;131(1097-685X (Electronic), 3):679-85.
120. Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Current Medical Research and Opinion 2007;23(1473-4877 (Electronic), 8):1783-90.
121. Deng MC, Dasch B, Erren M, Mollhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. The Annals of Thoracic Surgery 1996;62(1):184-90. [PUBMED: 8678641]
122. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. Journal of the American College of Cardiology 2009;54(6):558-65. [PUBMED: 19643320]
123. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56(2):455-63. [PUBMED: 10877304]
124. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629-34. [PUBMED: 9310563]
125. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110(1524-4539 (Electronic), 2):227-39.
126. Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M, et al. Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. The Thoracic and Cardiovascular Surgeon 2009;57(6):315-23. [PUBMED: 19707971]
127. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. The Journal of Thoracic and Cardiovascular Surgery 1994;108(4):626-35. [PUBMED: 7934095]
128. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [PUBMED: 12111919]
129. Higgins JPT, Green S. Highly sensitive filter for randomised controlled trials. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008.
130. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006;105(0003-3022 (Print), 6):1260-72.
131. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 2006;333(1468-5833 (Electronic), 7579):1149.
132. Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 2000;102(1524-4539 (Electronic), 2):157-65.
133. Kulik A, Levin R, Ruel M, Mesana TG, Solomon DH, Choudhry NK. Patterns and predictors of statin use after coronary artery bypass graft surgery. Journal of Thoracic and Cardiovascular Surgery 2007;134(1097-685X (Electronic), 4):932-8.
134. Lazar HL, Bao Y, Zhang Y, Bernard SA. Pretreatment with statins enhances myocardial protection during coronary revascularization. Journal of Thoracic and Cardiovascular Surgery 2003;125(0022-5223 (Print), 5):1037-42.
135. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org. [PUBMED: 18826567]
136. Liakopoulos OJ, Muhlfeld C, Koschinsky M, Coulibaly MO, Schondube FA, Dorge H. Progressive loss of myocardial contractile function despite unimpaired coronary blood flow after cardiac surgery. Basic Research in Cardiology 2005;100(1):75-83. [PUBMED: 15580517]
137. Liakopoulos OJ, Teucher N, Muhlfeld C, Middel P, Heusch G, Schoendube FA, et al. Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. European Journal of Cardio-thoracic Surgery 2006;30(2):263-70. [PUBMED: 16829094]
138. Liakopoulos OJ, Schmitto JD, Kazmaier S, Brauer A, Quintel M, Schoendube FA, et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. The Annals of Thoracic Surgery 2007;84(1):110-8; discussion 118-9. [PUBMED: 17588396]
139. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30, 000 patients. European Heart Journal 2008;29(12):1548-59. [PUBMED: 18506053]
140. Liakopoulos OJ, Choi YH, Kuhn EW, Wittwer T, Borys M, Madershahian N, et al. Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review. The Journal of Thoracic and Cardiovascular Surgery 2009;138(3):678-86.e1. [PUBMED: 19698856]
141. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004;291(1538-3598 (Electronic), 17):2092-9.
142. Ludman A, Venugopal V, Yellon DM, Hausenloy DJ. Statins and cardioprotection - more than just lipid lowering?. Pharmacology & Therapeutics 2009;122(1):30-43. [PUBMED: 19318042]
143. Mohammed AA, Agnihotri AK, van Kimmenade RR, Martinez-Rumayor A, Green SM, Quiroz R, et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 2009;120(10):843-50. [PUBMED: 19704098]
144. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896-900. [PUBMED: 10584742]
145. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [PUBMED: 19621072]
146. Muhlfeld C, Liakopoulos OJ, Schaefer IM, Schondube FA, Richter J, Dorge H. Methylprednisolone fails to preserve pulmonary surfactant and blood-air barrier integrity in a porcine cardiopulmonary bypass model. The Journal of Surgical Research 2008;146(1):57-65. [PUBMED: 17583746]
147. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. European Journal of Cardio-thoracic Surgery 2002;21(2):232-44. [PUBMED: 11825729]
148. Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005;111(16):2099-106. [PUBMED: 15750189]
149. Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. Journal of the American College of Cardiology 2007;49(12):1272-8. [PUBMED: 17394957]
150. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107(1524-4539 (Electronic), 14):1848-51.
151. Powell BD, Bybee KA, Valeti U, Thomas RJ, Kopecky SL, Mullany CJ, et al. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. American Journal of Cardiology 2007;99(0002-9149 (Print), 6):785-9.
152. Qing M, Vazquez-Jimenez JF, Klosterhalfen B, Sigler M, Schumacher K, Duchateau J, et al. Influence of temperature during cardiopulmonary bypass on leukocyte activation, cytokine balance, and post-operative organ damage. Shock (Augusta, Ga.) 2001;15(5):372-7. [PUBMED: 11336197]
153. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. New England Journal of Medicine 1996;335(0028-4793 (Print), 14):1001-9.
154. Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. The New England Journal of Medicine 2009;361(10):980-9. [PUBMED: 19726772]
155. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England Journal of Medicine 2009;360(10):961-72. [PUBMED: 19228612]
156. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(25 Suppl 2):S1-45. [PUBMED: 24222016]
157. Takagi H, Umemoto T. A meta-analysis of controlled studies of preoperative statin therapy for prevention of postoperative mortality in cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery 2009; Vol. 138, issue 3:790-1; author reply 792. [PUBMED: 19698886]
158. Valen G, Paulsson G, Bennet AM, Hansson GK, Vaage J. Gene expression of inflammatory mediators in different chambers of the human heart. The Annals of Thoracic Surgery 2000;70(2):562-7. [PUBMED: 10969681]
159. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. Journal of the American College of Cardiology 2001;38(2):307-14. [PUBMED: 11499717]
160. Verrier ED, Shernan SK, Taylor KM, Van de Werf F, Newman MF, Chen JC, et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 2004;291(19):2319-27. [PUBMED: 15150203]
161. White CW, Gobel FL, Campeau L, Knatterud GL, Forman SA, Forrester JS, et al. Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation 2001;104(1524-4539 (Electronic), 22):2660-5.
162. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. Journal of the American College of Cardiology 2010;56(14):1099-109. [PUBMED: 20825761]
163. Yin L, Wang Z, Wang Y, Ji G, Xu Z. Effect of statins in preventing postoperative atrial fibrillation following cardiac surgery. Heart, Lung & Circulation 2010;19(10):579-83. [PUBMED: 20800542]
164. Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. The Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008493.pub2]
165. Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. The Cochrane Database of Systematic Reviews 2012;4:CD008493. [PUBMED: 22513959]